Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1344 ARTÍCULOS , VIENDO DEL 286 AL 300

Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography

Wolk DA, Zhang Z, Boudhar S, Clark CM, Pontecorvo MJ, Arnold SE.

J Neurol Neurosurg Psychiatry. 2012 Sep;83(9):923-6. doi: 10.1136/jnnp-2012-302548. Epub 2012 Jul 11.

Continuing donepezil produces cognitive benefits in Alzheimer's

Bland P.

Practitioner. 2012 Apr;256(1750):5.

Bioinorganic chemistry of Alzheimer's disease

Kepp KP.

Chem Rev. 2012 Oct 10;112(10):5193-239. doi: 10.1021/cr300009x. Epub 2012 Jul 13.

Randomized, double-blind, parallel-group, 48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm²) in Alzheimer's disease

Cummings J, Froelich L, Black SE, Bakchine S, Bellelli G, Molinuevo JL, Kressig RW, Downs P, Caputo A, Strohmaier C.

Dement Geriatr Cogn Disord. 2012;33(5):341-53. doi: 10.1159/000340056. Epub 2012 Jul 11.

Potential use of γ-secretase modulators in the treatment of Alzheimer disease

Wagner SL, Tanzi RE, Mobley WC, Galasko D.

Arch Neurol. 2012 Oct;69(10):1255-8. doi: 10.1001/archneurol.2012.540.

[Chinese herbal medicine for patients with mild to moderate Alzheimer disease based on syndrome differentiation: a randomized controlled trial]

Yu L, Lin SM, Zhou RQ, Tang WJ, Huang PX, Dong Y, Wang J, Yu ZH, Chen JL, Wei L, Xing SL, Cao HJ, Zhao HB.

Zhong Xi Yi Jie He Xue Bao. 2012 Jul;10(7):766-76. doi: 10.3736/jcim20120707.

Alzheimer's disease Aβ assemblies mediating rapid disruption of synaptic plasticity and memory

Klyubin I, Cullen WK, Hu NW, Rowan MJ.

Mol Brain. 2012 Jul 17;5:25. doi: 10.1186/1756-6606-5-25.

Neddylation dysfunction in Alzheimer's disease

Chen Y, Neve RL, Liu H.

J Cell Mol Med. 2012 Nov;16(11):2583-91. doi: 10.1111/j.1582-4934.2012.01604.x.

Brain aging and late-onset Alzheimer's disease: many open questions

Behl C.

Int Psychogeriatr. 2012 Aug;24 Suppl 1:S3-9. doi: 10.1017/S104161021200052X.

Cerebral blood flow regulation by nitric oxide in Alzheimer's disease

Toda N, Okamura T.

J Alzheimers Dis. 2012;32(3):569-78. doi: 10.3233/JAD-2012-120670.

The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization

Hamley IW.

Chem Rev. 2012 Oct 10;112(10):5147-92. doi: 10.1021/cr3000994. Epub 2012 Jul 19.

Disease modifying drugs targeting β-amyloid

Ozudogru SN, Lippa CF.

Am J Alzheimers Dis Other Demen. 2012 Aug;27(5):296-300. doi: 10.1177/1533317512452034.

Endoplasmic reticulum enrollment in Alzheimer's disease

Viana RJ, Nunes AF, Rodrigues CM.

Mol Neurobiol. 2012 Oct;46(2):522-34. doi: 10.1007/s12035-012-8301-x. Epub 2012 Jul 20.

The relationship between subcortical tau pathology and Alzheimer's disease

Attems J, Thal DR, Jellinger KA.

Biochem Soc Trans. 2012 Aug;40(4):711-5. doi: 10.1042/BST20120034.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias